BRIEF-Casi Pharmaceuticals Signs Agreement To Acquire Equity Interests In Precision Autoimmune Therapeutics

Reuters
04 Apr
BRIEF-Casi Pharmaceuticals Signs Agreement To Acquire Equity Interests In Precision Autoimmune <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

April 3 (Reuters) - CASI Pharmaceuticals Inc CASI.O:

  • CASI PHARMACEUTICALS INC: SIGNS AGREEMENT TO ACQUIRE EQUITY INTERESTS IN PRECISION AUTOIMMUNE THERAPEUTICS

  • CASI PHARMACEUTICALS: TO ACQUIRE ALL OF EQUITY INTEREST IN PRECISION AUTOIMMUNE THERAPEUTICS AT RMB28.4 MILLION

Source text: [ID:n0001104659-25-031711]

Further company coverage: CASI.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10